WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[Tianyin Pharmaceutical Co., Inc. BY-LAWS ARTICLE I Stockholders 1. Annual Meeting 2. Special Meetings . Special meetings of the stockholders, for any purpose or purposes prescribed in the notice of the meeting, may be called by the Board of Directors or the chief executive officer and shall be held at such place, on such date, and at such time as] []
TPI [TIANYIN PHARMACEUTICAL] 8-K: Tianyin Pharmaceutical Co., Inc. BY-LAWS ARTICLE I Stockholders
[Tianyin Pharmaceutical Co., Inc. BY-LAWS ARTICLE I Stockholders 1. Annual Meeting 2. Special Meetings . Special meetings of the stockholders, for any purpose or purposes prescribed in the notice of the meeting, may be called by the Board of Directors or the chief executive officer and shall be held at such place, on such date, and at such time as] []
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13D/A: (Original Filing)
[13D CUSIP No. 830884102 Page 2 1. Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons John M. Gregory 2. Check the Appropriate Box if a Member of a Group (See Instructions) ¨ x (a) 3. SEC Use Only 4. Source of Funds (See Instructions) OO 5. 6.]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13D/A: 13D CUSIP No. 830884102 Page 2 1. Names
[13D CUSIP No. 830884102 Page 2 1. Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons John M. Gregory 2. Check the Appropriate Box if a Member of a Group (See Instructions) ¨ x (a) 3. SEC Use Only 4. Source of Funds (See Instructions) OO 5. 6.]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), announced that the Company's Annual Meeting of Shareholders for fiscal year ended June 30, 2014 which was scheduled to] []
